Francis Jacob

Basel, BS 4056, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practice.

Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practice.

Journal: Critical reviews in oncology/hematology
Published: January 20, 2026

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Journal: Nature medicine
Published: August 01, 2025

zAvatar-test-A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical study.

zAvatar-test-A functional precision model to personalize ovarian cancer treatments: Results from a co-clinical study.

Journal: Cell reports. Medicine
Published: August 01, 2025

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.

Journal: NPJ precision oncology
Published: June 12, 2025

NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma.

NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma.

Journal: Nature communications
Published: April 25, 2025

Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis.

Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis.

Journal: International journal of molecular sciences
Published: March 21, 2025

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

Journal: Nature communications
Published: March 09, 2025

P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.

P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.

Journal: Virchows Archiv : an international journal of pathology
Published: February 13, 2025

High-resolution imaging mass cytometry to map subcellular structures.

High-resolution imaging mass cytometry to map subcellular structures.

Journal: Nature methods
Published: January 31, 2025

Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming.

Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming.

Journal: Nature communications
Published: December 20, 2024

Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment.

Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment.

Journal: NPJ precision oncology
Published: November 06, 2024

161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer.

161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 04, 2024
Showing 1-12 of 65

Last Updated: 09/26/2026